The outlook of companies tied to Viagra's legacy presents a challenging investment scenario . While the initial boom generated substantial returns , generic copies have significantly eroded sales . Investing in connected pharmaceutical companies now requires a careful assessment of intellectual property protection , evolving medical changes, and th